Aclarion Announces Presentation of Two Abstracts Highlighting Nociscan’s Growing Role in Real-World Clinical Practice

Go back to Aclarion Announces Presentation of Two Abstracts Highlighting Nociscan’s Growing Role in Real-World Clinical Practice
(NASDAQ: ACON) Delayed: 2.52 -0.12 (4.55%)
Previous Close $2.64    52 Week High
Open $2.59    52 Week Low
Day High $2.64    P/E N/A 
Day Low $2.47    EPS
Volume 15,735       

(NASDAQ: ACONW) Delayed: 0.03 --0 (-0%)
Previous Close $0.03    52 Week High
Open $0.03    52 Week Low
Day High $0.03    P/E N/A 
Day Low $0.03    EPS
Volume 38,535